Cargando…
晚期肺腺癌患者一线治疗前后EGFR基因突变差异性分析
BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor (EGFR)-based targeted therapy improves the survival of patients with advanced lung adenocarcinoma harboring EGFR mutations. However, factors including treatment or heterogeneity partly contribute to EGFR genetic status alteration between bas...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246999/ https://www.ncbi.nlm.nih.gov/pubmed/30454543 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.11.03 |